"The 'catfish effect' in the medical insurance catalog stirs up the GLP-1 track, and the prices of many drugs purchased on Meituan have been loosened."

Recently, the innovative drug Tirzepatide under the Eli Lilly company has been officially included in the new national medical insurance catalog, leading to a new round of price reduction in the domestic market for diabetes and weight loss medications. According to actual tests, before the medical insurance price of Tirzepatide is implemented, some online pharmaceutical platforms have already started to offer discounts through pre-sale activities. Meituan Pharmacies displays that the pre-sale price for the 10mg dosage of Tirzepatide is as low as 450 yuan, equivalent to about 20% of the previous price. At the same time, online prices for other GLP-1 medications such as semaglutide have also been adjusted to varying degrees, revealing the gradual transmission effect of medical insurance policies on prices in the outpatient market.